Get a high resolution logo for any domain or stock ticker — for free

Orum Therapeutics, Inc., a biotechnology company, engages in the research and development of pharmaceuticals for cancer and immune diseases. It develops ORM-5029 for the treatment of breast cancer; ORM-6151 to treat acute myeloid leukemia; and ORM-1023 for the treatment of small cell lung cancer and neuroendocrine tumor. The company also develops dual-precision targeted protein stabilization PROTAb and casitas B lymphoma-b platforms and programs. Orum Therapeutics, Inc. was founded in 2016 and is based in Daejeon, South Korea.